Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management

touchCASES for touchONCOLOGY Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.      The experts: Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy Dr Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchONCOLOGY.com